Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity

Yuguang Shi, Paul Burn

Research output: Contribution to journalReview article

229 Scopus citations

Abstract

Obesity is a complex disease that is regulated by both central and peripheral mechanisms. New medicines for the treatment and prevention of obesity will need to overcome the powerful compensatory responses of the overlapping, and often redundant, networks that have evolved to safeguard efficient energy use. Despite great progress in the identification of central signals that regulate satiety, and considerable investment in the development of appetite-controlling medications, success has been modest so far. Here we review the main enzymes that are involved in different stages of lipid metabolism - from digestion and absorption through synthesis and storage to mobilization and oxidation - which might be successfully targeted by new pharmacotherapies.

Original languageEnglish (US)
Pages (from-to)695-710
Number of pages16
JournalNature Reviews Drug Discovery
Volume3
Issue number8
DOIs
StatePublished - Aug 2004

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this